BioCentury
ARTICLE | Clinical News

Introgen, VirRx Inc. preclinical data

June 16, 2003 7:00 AM UTC

In INGN 007 suppressed human cancer xenografts in nude mice. INGN exclusively licensed the technology from VirRx. Data were presented at the American Society of Gene Therapy meeting in Washington D.C....